DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Badrising S, van der Noort V, van Oort IM. et al.
Clinical Activity and Tolerability of enzalutamide in Patients With mCRPC Who Progress After Docetaxel and Abiraterone Treatment.
Cancer 2014;
120: 968-975
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.